Related Experiment Video

Updated: Apr 7, 2026

Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness
08:52

Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness

Published on: March 18, 2022

3.6K

Osteopontin inhibits HIF-2α mRNA expression in osteoarthritic chondrocytes

Chao Cheng1, Fang-Jie Zhang1, Jian Tian1

  • 1Department of Orthopaedics, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, P.R. China.

Experimental and Therapeutic Medicine
|July 3, 2015
PubMed

Insights

Osteopontin (OPN) may protect against osteoarthritis (OA) by reducing hypoxia-inducible factor-2α (HIF-2α) in cartilage cells. This protective effect involves OPN interacting with CD44, suggesting a novel therapeutic target for OA.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Orthopedics

Background:

  • Osteoarthritis (OA) is a degenerative joint disease characterized by cartilage breakdown.
  • Osteopontin (OPN) and hypoxia-inducible factor-2α (HIF-2α) are implicated in OA pathogenesis.
  • Understanding the molecular interplay between OPN and HIF-2α in chondrocytes is crucial for developing targeted OA therapies.

Purpose of the Study:

  • To investigate the in vitro effect of osteopontin (OPN) on hypoxia-inducible factor-2α (HIF-2α) expression in chondrocytes.
  • To elucidate the role of OPN in osteoarthritis (OA) pathogenesis.
  • To explore the potential interaction between OPN and CD44 in regulating HIF-2α expression.

Main Methods:

  • Chondrocytes were isolated from OA patient cartilage and cultured in vitro.
  • Cells were treated with recombinant human OPN (rhOPN) or OPN small interfering RNA (siRNA).
  • mRNA expression levels of OPN and HIF-2α were quantified using RT-qPCR; CD44 blocking antibody was used to assess ligand-receptor interactions.

Main Results:

  • Recombinant OPN treatment significantly decreased HIF-2α mRNA expression in chondrocytes.
  • OPN siRNA treatment led to increased HIF-2α gene expression.
  • Blocking CD44 with a monoclonal antibody attenuated the inhibitory effect of OPN on HIF-2α expression.

Conclusions:

  • Osteopontin (OPN) exhibits a protective role in osteoarthritis (OA) by inhibiting HIF-2α gene expression in chondrocytes.
  • The interaction between OPN and CD44 is critical for OPN's inhibitory effect on HIF-2α.
  • These findings suggest that targeting the OPN-CD44 pathway may offer a therapeutic strategy for OA.
Keywords:
CD44HIF-2αchondrocyteosteoarthritisosteopontin

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.8K
Bone Formation by Endochondral Ossification01:24

Bone Formation by Endochondral Ossification

Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...
14.7K